Welcome to our dedicated page for Chemours news (Ticker: CC), a resource for investors and traders seeking the latest updates and insights on Chemours stock.
The Chemours Company reports developments for a global industrial and specialty chemicals business organized around Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. News commonly covers earnings releases, quarterly dividends, debt financing, and segment demand for products sold under brands including Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™.
Company updates also address refrigerants and thermal-management applications, TiO2 pigment pricing and volume trends, advanced fluoropolymers for semiconductor and electronics markets, and collaborations tied to high-density IT cooling and other specialty-chemistry uses.
Chemours (NYSE: CC) priced an upsized private offering of $700,000,000 aggregate principal amount of 7.875% senior notes due March 15, 2034, up from a previously announced $600,000,000.
Interest will be paid semi‑annually starting September 15, 2026; closing is expected March 12, 2026. Net proceeds are intended to fund redemptions of the company's 5.375% senior notes due 2027 and a partial redemption of its 5.750% senior notes due 2028.
Chemours (NYSE: CC) announced a proposed private offering of $600,000,000 aggregate principal amount of senior notes due 2034 on February 26, 2026. The Notes will be senior unsecured obligations and guaranteed by a Chemours subsidiary.
The company intends to use net proceeds to fund the redemption of its outstanding 5.375% senior notes due 2027 and to fund the redemption or repurchase of a portion of its outstanding 5.750% senior notes due 2028. The offering is being made only to qualified institutional buyers under Rule 144A or to non-U.S. persons under Regulation S and the Notes have not been registered under the Securities Act.
Chemours (NYSE: CC) and 2CRSi announced a Joint Development Agreement on Feb 24, 2026 after qualifying Chemours' Opteon™ two-phase immersion cooling fluid in 2CRSi servers.
The partnership aims to accelerate two-phase direct-to-chip and immersion cooling for high-density AI and HPC servers, claiming up to 90% cooling energy reduction and PUE near 1.
Chemours (NYSE: CC) announced that Gerardo Familiar, President of its Advanced Performance Materials business, was appointed to the SEMI North America Advisory Board, effective Jan. 14, 2026, for a three-year term.
Familiar brings more than 25 years of global experience and will advise on semiconductor supply chain resilience, sustainability, workforce development, and manufacturing excellence.
Chemours (NYSE: CC) reported Q4 2025 net sales of $1.3B and a Q4 net loss attributable to Chemours of $47M ($0.31 diluted EPS). Full‑year 2025 net sales were $5.8B with a net loss of $386M ($2.57). Adjusted EBITDA was $128M for Q4 and $742M for FY2025.
The company noted record TSS results driven by Opteon refrigerants, implemented a TiO2 price increase effective Dec 1, 2025, and expects 2026 Adjusted EBITDA of $800M–$900M with net sales growth of 3–5%.
Chemours (NYSE: CC) announced a quarterly cash dividend of $0.0875 per share for the first quarter of 2026. The dividend is payable on March 13, 2026 to holders of record at the close of business on February 27, 2026.
This action signals a current cash return to shareholders for Q1 2026.
Chemours (NYSE: CC) expects to release its fourth quarter 2025 financial results after market on Thursday, February 19, 2026 and to host a public webcast conference call at 8:00 a.m. ET on Friday, February 20, 2026.
Investors can access the live webcast, accompanying slides, and a replay via the Events and Presentations section of Chemours' Investor Relations website at investors.chemours.com.
Chemours (NYSE: CC) signed definitive agreements on Jan. 15, 2026 to sell the remaining land at its former titanium dioxide manufacturing site in Kuan Yin, Taiwan to an ownership group including Century Wind Power, Century Iron & Steel Industrial, and Century Huaxin Wind Energy.
The land sale is expected to generate approximately $360 million in gross cash proceeds, prior to customary taxes and fees, and is expected to substantially close by mid‑year 2026 subject to local regulatory approval, inclusive of environmental conditions. The company said it will apply the cash proceeds to reduce its debt obligations.
Chemours (NYSE: CC) appointed Michael Foley as President of Titanium Technologies, effective February 2026, and announced the departure of Damián Gumpel.
The company said CEO Denise Dignam will provide leadership support during the transition. Foley previously led a $1 billion Formulated Specialties portfolio at Momentive, overseeing 8 manufacturing sites and 2,000 employees, and has experience in Lean and Six Sigma. Chemours said the move supports its TT value-based strategy and ongoing execution of the Pathway to Thrive plan for titanium dioxide (TiO2) markets.
Chemours (NYSE: CC) reported Q3 2025 net sales of $1.5B (flat YoY) and net income of $60M or $0.40 per diluted share versus a loss year-ago. Adjusted EBITDA was $195M versus $202M a year earlier. Key segment drivers included TSS Opteon™ revenue up 80% YoY and TSS Adjusted EBITDA of $194M (+40% YoY).
TT Adjusted EBITDA fell to $25M (down 68% YoY) and APM Adjusted EBITDA fell to $14M with outage-related costs ~$20M. Net debt was $3.6B (gross debt $4.2B) and net leverage ~4.6x. Q4 2025 guidance: consolidated Adjusted EBITDA $130–160M and sequential net sales down 10–15%.